HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dimitrios Mougiakakos Selected Research

salicylhydroxamic acid (SHAM)

11/2022Feasibility, Safety, and Preliminary Efficacy of Very Low-Volume Interval Training in Advanced Cancer Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dimitrios Mougiakakos Research Topics

Disease

42Neoplasms (Cancer)
03/2024 - 12/2008
7Lymphoma (Lymphomas)
03/2024 - 01/2021
6Multiple Myeloma
03/2024 - 11/2018
6Inflammation (Inflammations)
01/2023 - 01/2015
6Melanoma (Melanoma, Malignant)
08/2012 - 07/2009
5Autoimmune Diseases (Autoimmune Disease)
04/2024 - 01/2022
5B-Cell Lymphoma (Lymphoma, B Cell)
12/2023 - 04/2015
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2023 - 01/2018
5Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 01/2011
4Infections
01/2024 - 01/2016
4Hypoxia (Hypoxemia)
01/2023 - 05/2015
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2024 - 10/2022
3Neutropenia
11/2023 - 12/2021
2Disease Progression
06/2024 - 06/2010
2Myasthenia Gravis
06/2024 - 11/2023
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2023 - 06/2023
2Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 01/2021
2Thrombocytopenia (Thrombopenia)
08/2022 - 01/2021
2Leukemia
01/2021 - 11/2020
2Neoplasm Metastasis (Metastasis)
01/2017 - 06/2010
1Neuromyelitis Optica (Devic's Disease)
06/2024
1Multiple Sclerosis
06/2024
1Systemic Scleroderma (Systemic Sclerosis)
02/2024
1Myositis (Idiopathic Inflammatory Myopathies)
02/2024
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2024
1Flushing
01/2024
1Legionellosis
01/2024
1Antisynthetase syndrome
11/2023
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2023
1Arthritis (Polyarthritis)
01/2023
1Colitis
01/2023
1Diarrhea
01/2023
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023
1Sepsis (Septicemia)
11/2022
1Fatigue
11/2022
1Body Weight (Weight, Body)
10/2022
1Sarcopenia
10/2022
1Polycythemia Vera
05/2022

Drug/Important Bio-Agent (IBA)

12Chimeric Antigen ReceptorsIBA
06/2024 - 01/2021
5Biomarkers (Surrogate Marker)IBA
03/2024 - 08/2012
5Reactive Oxygen Species (Oxygen Radicals)IBA
05/2022 - 04/2009
4Glucose (Dextrose)FDA LinkGeneric
01/2023 - 05/2015
4AntigensIBA
01/2012 - 01/2009
3Rituximab (Mabthera)FDA Link
11/2023 - 04/2015
3Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2012
3Amino AcidsFDA Link
11/2020 - 05/2015
3Pemetrexed (MTA)FDA Link
01/2020 - 08/2016
2fludarabineIBA
02/2024 - 10/2022
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2024 - 10/2022
2Tyrosine Kinase InhibitorsIBA
11/2023 - 01/2023
2Monoclonal AntibodiesIBA
11/2023 - 11/2018
2Complement System Proteins (Complement)IBA
06/2023 - 11/2021
2Transcription Factors (Transcription Factor)IBA
01/2023 - 01/2017
2tisagenlecleucelIBA
01/2023 - 12/2021
2DNA (Deoxyribonucleic Acid)IBA
10/2022 - 03/2011
2Matrix Metalloproteinases (MMPs)IBA
05/2022 - 08/2016
2CytokinesIBA
12/2021 - 10/2015
2InflammasomesIBA
11/2021 - 10/2021
2Lactic Acid (Lactate)FDA LinkGeneric
12/2020 - 05/2015
25'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA
01/2020 - 08/2016
25'-methylthioadenosineIBA
01/2020 - 08/2016
2ElementsIBA
11/2017 - 08/2016
2Carrier Proteins (Binding Protein)IBA
11/2017 - 08/2016
2CatalaseIBA
01/2016 - 12/2008
2ErbB Receptors (EGF Receptor)IBA
10/2012 - 03/2012
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2010 - 07/2009
1Myelin-Oligodendrocyte GlycoproteinIBA
06/2024
1CalciumIBA
03/2024
1Thrombopoietin (c-mpl Ligand)IBA
03/2024
1ErythropoietinFDA Link
03/2024
1Peracetic Acid (Peroxyacetic Acid)IBA
01/2024
1Oncogene Proteins (Oncogene Protein)IBA
11/2023
1CD19 AntigensIBA
11/2023
1B-Cell Maturation AntigenIBA
11/2023
1B7-H1 AntigenIBA
01/2023
1Uric Acid (Urate)IBA
01/2023
1Hypoxia-Inducible Factor 1IBA
01/2023
1GSK1210151AIBA
01/2023
1ZymosanIBA
01/2023
1Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2023
1KynurenineIBA
01/2023
1Immune Checkpoint ProteinsIBA
01/2023
1S100 Proteins (S 100 Protein)IBA
11/2022
1Oxygen (Dioxygen)IBA
11/2022
1salicylhydroxamic acid (SHAM)IBA
11/2022
1AutoantibodiesIBA
10/2022
1obinutuzumabIBA
08/2022
1Intravenous Immunoglobulins (IVIG)FDA Link
08/2022

Therapy/Procedure

23Therapeutics
06/2024 - 01/2010
10Immunotherapy
02/2024 - 12/2008
6Stem Cell Transplantation
03/2024 - 02/2016
3Drug Therapy (Chemotherapy)
03/2024 - 01/2022
2Hematopoietic Stem Cell Transplantation
01/2021 - 01/2020
1Bathroom Equipment
01/2024
1Cell Transplantation
12/2023
1Salvage Therapy
12/2023
1Cell- and Tissue-Based Therapy (Cell Therapy)
11/2023
1Aftercare (After-Treatment)
06/2023
1Injections
01/2023
1Central Venous Catheters
11/2022